ProBioGenCancer vaccinesTransgene and ProBioGen forge partnershipThe Strasbourg-based biotech company Transgene and the Berlin-based CDMO ProBioGen have entered into a licensing agreement to collaboratively advance the development of individualised cancer vaccine … more ➔
By Benff - Own work, CC BY-SA 4.0, https://commons.wikimedia.org/w/index.php?curid=128081038Novo NordiskNovo’s obesity blockbuster semaglutide before label extensionIn both, liver fibrosis and resolution of MASH, Novo Nordisk’s GLP1 modulator semaglutide has shown convincing results in the Phase III ESSENCE study suggesting a label extension of the obesity bloc … more ➔
© Niclas Jessen Studio/Bracco Imaging SpAFinancingBlue Therapeutics gets financing to push radiotherapiesRadiopharmaceuticals specialist Blue Earth Therapeutics Ltd will use a U$76.5m Series A financing to finance Phase II development of its targeted prostate cancer radiopharmaceuticals Lutetium (177-Lu) … more ➔
EniferNovel FoodEnifer files for EFSA authorisation of mycoproteinAs the first Nordic company seeking Novel Food approval for a mycoprotein ingredient, Finnish Enifer has filed a authorisation application for it brand PEKILO to the EU food watchdog EFSA. more ➔
Knowledge Seeker - wikipedia.orgDigital PathologyAIgnostics raises US$34m in Series B financingDigital pathology specialist AIgnostics GmbH has topped up its cash position to US$55m with a US$34m Series B financing. The money will be used to optimise the company’s RudolfV Foundation Model and … more ➔
Resalis/VimeoCollaborationResalis Therapeutics gets equity investment from SanofiItalian obesity gene therapy developer Resalis Therapeutics srl has gained an equity investment from French pharma major Sanofi SA sufficient to finance its miRNA-22 antisense blocker RES-010 through … more ➔
UCB SApartnershipCancer UK/UCB collaboration: study with 2nd compound startedBelgian UCB SA and British Cancer UK have started a second clinical study within their multi-year partnership to evaluate the safety and tolerable dose of UCB4594 in patients with advanced cancers. more ➔
123rf.com/IculigAgomabAgomab raises US$89m in Series DAnother strong financing round for Belgian Agomab NV. Sanofi is joining the band wagon of targeting the TGFbeta receptor. more ➔
Rentschler Biopharma SEBiomanufacturingRentschler with double-digit investment in GermanyRentschler Biopharma announces largest single investment in the higher double-digit range at its headquarters in Germany for construction of a new buffer media facility in Laupheim. more ➔
Roche, Herzog&De MeuronAlzheimer’s DiseaseRoche leaves Alzheimer partnership with UCBRoche drops a third Alzheimer’s candidate this year, leaving a partnership with UCB just four years after agreeing to work together on new treatments for the neurological disease. more ➔
ProBioGen
By Benff - Own work, CC BY-SA 4.0, https://commons.wikimedia.org/w/index.php?curid=128081038
© Niclas Jessen Studio/Bracco Imaging SpA
Enifer
Knowledge Seeker - wikipedia.org
Resalis/Vimeo
UCB SA
123rf.com/Iculig
Rentschler Biopharma SE
Roche, Herzog&De Meuron